|
|
Quality of advanced ovarian cancer surgery: A French assessment of ESGO quality indicators
Marie-Mélanie Gac
,
Cécile Loaec
,
Johanna Silve
,
Edouard Vaucel
,
Paule Augereau
,
et al.
Journal articles
inserm-03349231v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
Nasim Mavaddat
,
Antonis C. Antoniou
,
Thea Mooij
,
Maartje Hooning
,
Bernadette Heemskerk-Gerritsen
,
et al.
Journal articles
inserm-02445596v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model
Gwenaelle Gravis
,
Jean-Marie Boher
,
Karim Fizazi
,
Florence Joly
,
Franck Priou
,
et al.
Journal articles
inserm-03353959v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1/2 carrier cohort (GENEPSO).
Julie Lecarpentier
,
Catherine Noguès
,
Emmanuelle Mouret-Fourme
,
Marion Gauthier-Villars
,
Christine Lasset
,
et al.
Journal articles
inserm-00724092v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
TAXOMET : A French prospective multicentric randomized controlled phase II study comparing docetaxel plus metformin versus docetaxel plus placebo in mCRPC
Marc Pujalte Martin
,
Delphine Borchiellini
,
Brice Thamphya
,
Aline Guillot
,
Jean-Baptiste Paoli
,
et al.
Journal articles
hal-03413458v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel Testing
Fabienne Lesueur
,
Séverine Eon-Marchais
,
Sarah Bonnet-Boissinot
,
Juana Beauvallet
,
Marie-Gabrielle Dondon
,
et al.
Journal articles
hal-03345372v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
GENESIS: a French national resource to study the missing heritability of breast cancer
Olga M Sinilnikova
,
Marie-Gabrielle Dondon
,
Séverine Eon-Marchais
,
Francesca Damiola
,
Laure Barjhoux
,
et al.
Journal articles
hal-01662200v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Breast Cancer Risk Associated with Estrogen Exposure and Truncating Mutation Location in BRCA1/2 Carriers
Julie Lecarpentier
,
Catherine Nogues
,
Emmanuelle Mouret-Fourme
,
Bruno Buecher
,
Marion Gauthier-Villars
,
et al.
Journal articles
inserm-01990932v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Dépistage du cancer du sein : en route vers le futur
Suzette Delaloge
,
Thomas Bachelot
,
François-Clément Bidard
,
Marc Espie
,
Etienne Brain
,
et al.
Journal articles
inserm-01822723v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Mutation screening of MIR146A/B and BRCA1/2 3′-UTRs in the GENESIS study
Amandine Garcia
,
Monique Buisson
,
Francesca Damiola
,
Chloé Tessereau
,
Laure Barjhoux
,
et al.
Journal articles
inserm-01994617v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate Cancer
Marc Pujalte Martin
,
Delphine Borchiellini
,
Brice Thamphya
,
Aline Guillot
,
Jean-Baptiste Paoli
,
et al.
Journal articles
hal-03429419v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation
Maximiliano Ribeiro Guerra
,
Juliette Coignard
,
Séverine Eon-Marchais
,
Marie-Gabrielle Dondon
,
Dorothée Le Gal
,
et al.
Journal articles
hal-03345365v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2
Sophie Blein
,
Laure Barjhoux
,
Francesca Damiola
,
Marie-Gabrielle Dondon
,
Séverine Eon-Marchais
,
et al.
Journal articles
inserm-01991386v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial
Xavier Pivot
,
Gilles Romieu
,
Marc Debled
,
Jean-Yves Pierga
,
Pierre Kerbrat
,
et al.
The Lancet, 2019, 393 (10191), pp.2591-2598
Journal articles
inserm-02944688v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing
Elodie Girard
,
Séverine Eon‐marchais
,
Robert E Olaso
,
Anne‐laure Renault
,
Francesca Damiola
,
et al.
Journal articles
inserm-02438452v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Multiple myeloma treatment at relapse after autologous stem cell transplantation: a practical analysis
F. Malard
,
J.L. Harousseau
,
M. Mohty
Journal articles
hal-01400036v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Early toxicity of a phase II trial of combined salvage radiotherapy and hormone therapy in oligometastatic pelvic node relapses of prostate cancer (OLIGOPELVIS GETUG P07)
Loig Vaugier
,
Clément Palpacuer
,
Emmanuel Rio
,
Aurore Goineau
,
David Pasquier
,
et al.
Journal articles
inserm-01980788v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacy of anthracycline/taxane-based neo-adjuvant chemotherapy on triple-negative breast cancer in BRCA1 / BRCA2 mutation carriers
Lucie Bignon
,
Jean-Pierre Fricker
,
Catherine Noguès
,
Emmanuelle Mouret-Fourme
,
Dominique Stoppa-Lyonnet
,
et al.
Journal articles
hal-01960320v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Circulating Tumour Cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab
J-y Pierga
,
F-C Bidard
,
A. Autret
,
T. Petit
,
F. André
,
et al.
Journal articles
inserm-01985299v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Interferon-γ reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages
Dorothée Duluc
,
Murielle Corvaisier
,
Simon J. Blanchard
,
Laurent Catala
,
Philippe Descamps
,
et al.
Journal articles
inserm-03377765v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos channelopathy: a retrospective series of 126 patients
Veronique Picard
,
Corinne Guitton
,
Isabelle Thuret
,
Christian Rose
,
Laurence Bendelac
,
et al.
Journal articles
hal-02929666v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Gene‐ and pathway‐level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibility
Christine Lonjou
,
Séverine Eon‐marchais
,
Thérèse Truong
,
Marie‐gabrielle Dondon
,
Mojgan Karimi
,
et al.
Journal articles
hal-03345363v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|